Charles J Homcy insider trades: BridgeBio Pharma (BBIO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Charles reports to the SEC
and 6 more companies
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | BBIO | ↓ Sell | 300,000 | $46.37 | $13.9M | Direct | Aug 12, 2025 (1d) |
| Oct 16, 2020 | BBIO | ↓ Sell | 10,256 | $41.00 | $420K | Direct | Oct 19, 2020 (3d) |
| Sep 30, 2020 | BBIO | ↓ Sell | 10,000 | $38.00 | $380K | Direct | Oct 1, 2020 (1d) |
| Sep 29, 2020 | BBIO | ↓ Sell | 99,257 | $36.95 | $3.7M | Direct | Sep 29, 2020 (0d) |
| Feb 10, 2020 | BBIO | ↓ Sell | 20,000 | $36.00 | $720K | Direct | Feb 12, 2020 (2d) |
| Jan 14, 2020 | BBIO | ↓ Sell | 10,000 | $35.00 | $350K | Direct | Jan 16, 2020 (2d) |
| Dec 17, 2018 | PTLA | ↓ Sell | 64,218 | $18.61 | $1.2M | Direct | Dec 19, 2018 (2d) |
| Oct 27, 2017 | GBT | ↓ Sell | 70,000 | $33.97 | $2.4M | Direct | Oct 27, 2017 (0d) |
| Jun 23, 2017 | PTLA | ↓ Sell | 120,803 | $53.06 | $6.4M | Direct | Jun 27, 2017 (4d) |
| Jun 2, 2017 | GBT | ↓ Sell | 100,000 | $27.08 | $2.7M | Direct | Jun 22, 2017 (20d) |
| Mar 15, 2017 | PTLA | ↓ Sell | 50,000 | $40.06 | $2.0M | Direct | Mar 16, 2017 (1d) |
| Mar 1, 2017 | PTLA | ↓ Sell | 25,000 | $37.50 | $938K | Direct | Mar 3, 2017 (2d) |
| Sep 18, 2015 | PTLA | ↓ Sell10b5-1 | 40,067 | $56.25 | $2.3M | Direct | Sep 18, 2015 (0d) |
| Jul 13, 2015 | PTLA | ↓ Sell | 50,000 | $48.00 | $2.4M | Direct | Jul 14, 2015 (1d) |
| Jun 29, 2015 | PTLA | ↓ Sell | 100,000 | $43.78 | $4.4M | Direct | Jun 29, 2015 (0d) |
| Feb 23, 2015 | PTLA | ↓ Sell | 20,000 | $40.00 | $800K | Direct | Feb 23, 2015 (0d) |
| Feb 17, 2015 | PTLA | ↓ Sell | 20,000 | $36.00 | $720K | Direct | Feb 17, 2015 (0d) |
| Feb 13, 2015 | PTLA | ↓ Sell | 20,000 | $34.05 | $681K | Direct | Feb 13, 2015 (0d) |
| Jan 28, 2015 | PTLA | ↓ Sell | 19,700 | $30.00 | $591K | Direct | Jan 28, 2015 (0d) |
| Jan 27, 2015 | PTLA | ↓ Sell | 300 | $30.00 | $9K | Direct | Jan 27, 2015 (0d) |
| Oct 22, 2013 | PTLA | ↓ Sell | 95,962 | $23.75 | $2.3M | Direct | Oct 23, 2013 (1d) |
| Dec 11, 2007 | MLNM | ↓ Sell | 59,238 | $15.81 | $936K | Direct | Dec 13, 2007 (2d) |
| Sep 19, 2007 | MLNM | ↓ Sell | 90,000 | $10.42 | $938K | Direct | Sep 19, 2007 (0d) |
| Sep 4, 2007 | MLNM | ↓ Sell | 30,000 | $10.20 | $306K | Direct | Sep 6, 2007 (2d) |
| Feb 16, 2007 | MLNM | ↓ Sell | 27,774 | $11.24 | $312K | Direct | Feb 20, 2007 (4d) |
| Nov 21, 2006 | MLNM | ↓ Sell | 20,000 | $11.43 | $229K | Direct | Nov 21, 2006 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BBIO insiders
Open-market trades in the last 12 months
About Charles J Homcy's insider trades
Charles J Homcy is a director at BridgeBio Pharma (BBIO). Since Nov 21, 2006, Charles has reported no open-market purchases and 26 sales worth $51.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (4% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (51 filings), option exercises (31 filings), shares withheld for taxes (10 filings), gifts (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BBIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.